Work-related stress, associated comorbidities and stress causes in French community pharmacies: a nationwide crosssectional study
2017 - David Balayssac, Bruno Pereira, Julie Virot, Céline Lambert, Aurore Collin, David Alapini, Jean-Marc Gagnaire, Nicolas Authier, Damien Cuny, Brigitte Vennat PeerJ n°. - SOUS PRESSE
Agomelatine: a new opportunity to reduce neuropathic pain. Preclinical evidence.
2016 - Chenaf C1,Chapuy E,Libert F,Marchand F,Courteix C,Bertrand M,Gabriel C,Mocaër E,Eschalier A,Authier N pain n°158 - pp 149.160
Amyloid precursor-like protein 2 deletion-induced retinal synaptopathy related to congenital stationary night blindness: structural, fuctionnal and molecular characteristics
2016 - Dinet V,Ciccotosto G,Delaunay K,Borras C,Ranchon-Cole I,Kostic C. Mol Brain n°1 - pp 64
Class III myosins shape the auditory hair bundles by limiting microvilli and stereocilia growth
2016 - Lelli A,Michel V,Boutet-de-Monvel J,Cortese M,Bosch-Grau M,Aghaie A,Perfetti I,Dupont T,Avan P,El-Amraoui A,Petit C J Cell Biol n°212(2) - pp 231-244
Phloroglucinol protects retinal pigment epithelium and photoreceptor against all-trans-retinal-induced toxicity and inhibits A2E formation
2016 - Cia D,Cubizolle A,Crauste C,Jacquemot N,Guillou L,Vigor C,Angebault C,Hamel C,Vercauteren J,Brabet P J Cell Mol Med n°20 - pp 1651-63
Validation of a noninvasive test routinely used in otology for the diagnosis of cerebrospinal fluid shunt malfunction in patients with normal pressure hydrocephalus
2016 - Sakka L,Chomicki A,Gabrillargues J,Khalil T,Chazal J,Avan P J Neurosurg n°124(2) - pp 342-349
Activation of medullary dorsal horn PKCγ interneurons produces static as well as dynamic mechanical hypersensitivity
2016 - Pham-Dang N,Descheemaeker A,Dallel D,Artola A J Neurosci n°43(6) - pp 802/810
CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy
2016 - Pignolet B,Schwab N,Schneider-Hohendorf T,Bucciarelli F,Biotti D,Averseng-Peaureaux D,Outteryck O,Ongagna JC,de Sèze J,Brochet B,Ouallet JC,Debouverie M,Pittion S,Defer G,Derache N,Hautecoeur P,Tourbah A,Labauge P,Castelnovo G,Clavelou P,Berger E,Pelletier J,Rico A,Zéphir H,Laplaud D,Wiertlewski S,Camu W,Thouvenot E,Casez O,Moreau T,Fromont A,Vukusic S,Papeix C,Vermersch P,Comabella M,Lebrun-Frenay C,Wiendl H,Brassat D Neurology n°87(23) - pp 2491/2494
Co-occurrence of pain symptoms and somatosensory sensitivity in burning mouth syndrome: a systematic review
2016 - Moisset X,Calbacho V,Torres P,Gremeau-Richard C,Dallel R PloS One n°11 - x
Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study
2016 - Barbin L,Rousseau C,Jousset N,Casey R,Debouverie M,Vukusic S,De-Sèze J,Brassat D,Wiertlewski S, Brochet B, PelletierJ,Vermersch P,Edan G,Lebrun-Frenay C,Clavelou P,Thouvenot E,Camdessanché JP,Tourbah A,Stankoff B,Al Khedr A,Cabre P,Papeix C,Berger E,Heinzlef O,Debroucker T,Moreau T,GoutO,Bourre B,Créange A,Labauge P,Magy L,Defer G,FoucherY,Laplaud DA;CFSEP and OFSEP groups Neurology n°86(8) - pp 771/778.
Effects of glia metabolism inhibition on nociceptive behavioral testing in rats
2016 - Lefèvre Y,Amadio A,Vincent P,Descheemaeker A,Oliet SH,Dallel R,Voisin DL Data Brief n°7 - pp 372/375
Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study
2016 - Peyro Saint Paul L,Creveuil C,Heinzlef O,De Seze J,Vermersch P,Castelnovo G,Cabre P,Debouverie M,Brochet B,Dupuy B,Lebiez P,Sartori É,Clavelou P,Brassat D,Lebrun-Frenay C,Daplaud D,Pelletier J,Coman I,Hautecoeur P,Tourbah A,Defer G J Neurol Sci n°363 - pp 69/76
French Guidelines For the Emergency Management of Headaches
2016 - Moisset X,Mawet J,Guegan-Massardier E,Bozzolo E,Gilard V,Tollard E,Feraud T,Noëlle B,Rondet C,Donnet A Rev Neurol n°172 - pp 350/360
Geographical Heterogeneity of Multiple Sclerosis Prevalence in France
2016 - Pivot D,Debouverie M,Grzebyk M,Brassat D,Clanet M,Clavelou P,Confavreux C,Edan G,Leray E,Moreau T,Vukusic S,Hédelin G,Guillemin F PloS One n°11(12) - e0167556
Is there pain with neuropathic characteristics in patients with amyotrophic lateral sclerosis? A cross-sectional study
2016 - Moisset X,Cornut-Chauvinc C,Clavelou P,Pereira B,Rouvet C,Dallel R,Guy N Palliat Med n°30(5) - pp 486/494
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
2016 - Tourbah A,Lebrun-Frenay C,Edan G,Clanet M,Papeix C,Vukusic S,De Sèze J,Debouverie M,Gout O,Clavelou P,Defer G,Laplaud DA,Moreau T,Labauge P,Brochet B,Sedel F, Pelletier J; MS-SPI study group. Mult Scler n°22(13) - pp 1719/1731
Opioid use for the management of chronic non-cancer pain: French guidelines
2016 - Moisset X,Martinez V Rev Neurol n°172 - pp 337/338
Protein kinase Cγ Interneurons Mediates C-Fiber-Induced orofacial secondary static mechanical allodynia, but not C-fiber induced nociceptive behavior
2016 - Peirs C,Bourgois N,Artola A,Dallel R Anesthesiology n°124(5) - pp 1136/1152
Relationship between adaptation and cardiovascular response to tonic cold and heat pain Adaptability to tonic pain and cardiovascular responses
2016 - Devoize L,Chalaye P,Lafrenaye S,Marchand S,Dallel R Eur J Pain n°20(5) - pp 731/741
Use of strong opioids in chronic non-cancer pain in adults. Evidence-based recommendations from the French Society for the Study and Treatment of Pain
2016 - Moisset X,Trouvin AP,Tran VT,Authier N,Vergne-Salle P,Piano V,Martinez V Press Med n°45 - pp 447/462